tiprankstipranks
Advertisement
Advertisement
Amphastar downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe FlyAmphastar downgraded to Equal Weight from Overweight at Wells Fargo
2M ago
Amphastar price target lowered to $21 from $25 at Piper Sandler
Premium
The Fly
Amphastar price target lowered to $21 from $25 at Piper Sandler
2M ago
Amphastar Balances Margin Pain With Pipeline Gains
Premium
Company Announcements
Amphastar Balances Margin Pain With Pipeline Gains
2M ago
Amphastar downgraded to Hold from Buy at Jefferies
PremiumThe FlyAmphastar downgraded to Hold from Buy at Jefferies
3M ago
Amphastar price target lowered to $23 from $30 at Barclays
Premium
The Fly
Amphastar price target lowered to $23 from $30 at Barclays
3M ago
Amphastar Expands Share Repurchase Authorization to Manage Equity
Premium
Company Announcements
Amphastar Expands Share Repurchase Authorization to Manage Equity
4M ago
Amphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA
PremiumThe FlyAmphastar gets FDA approval for Ipratropium Bromide HFA Inhalation Aerosol ANDA
5M ago
AMPH Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
AMPH Upcoming Earnings Report: What to Expect?
5M ago
Amphastar Licenses ACTH Analog AMP-110 for North America
Premium
Company Announcements
Amphastar Licenses ACTH Analog AMP-110 for North America
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100